AOD-9604
Tyr-hGH Frag 177-191
Targeted fat loss without the systemic effects of growth hormone.
AOD-9604 is a modified fragment of human growth hormone (hGH), specifically the C-terminal region from amino acids 177-191. It was developed to isolate the fat-reducing effects of hGH without its muscle-building or insulin-desensitizing properties. This makes it a highly specific tool for research into lipolysis and metabolic regulation.
Read the research profile for mechanisms, citations, and safety context before comparing vendors. View the AOD-9604 research profile.
Key Benefits
Mechanism of Action
AOD-9604 works by stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the formation of new fat). It mimics the natural way hGH regulates fat metabolism but does so without binding to hGH receptors, thus avoiding unwanted side effects like increased IGF-1 levels or changes in blood sugar. It is thought to primarily target beta-3 adrenergic receptors, which are abundant in adipose tissue.
Dosing Guidelines
Typical Dose
300-500 mcg
Frequency
1x daily
Duration
12+ weeks
Note: Administer subcutaneously on an empty stomach, typically in the morning 30-60 minutes before food, to maximize lipolytic effects.
Research & Studies
A comprehensive overview of AOD-9604's mechanism, benefits, dosing protocols, and safety data.
Read Full ResearchReview of the clinical trials on AOD-9604's efficacy and safety for weight loss in obese human subjects.
Read Full ResearchComparing the different mechanisms of action between direct lipolytic agents like AOD-9604 and appetite suppressants like Semaglutide.
Read Full ResearchPotential Side Effects
Reported side effects may include:
- - Mild injection site reaction (redness, soreness)
- - Transient headache (rare)
- - Nausea or upset stomach (infrequent)
- - Potential for mild water retention
- - No significant impact on blood glucose or IGF-1 reported
This information is for research purposes only. Always consult with a healthcare professional.
Popular Stacking Options
AOD-9604 + CJC-1295 / Ipamorelin
Combines AOD-9604's direct fat-burning with the systemic metabolic and recovery benefits of a GHRH/GHRP stack for comprehensive body recomposition.
Shop this stackAOD-9604 + Tesamorelin
Stacks a direct lipolytic agent (AOD-9604) with a GHRH that specifically targets visceral adipose tissue, creating a powerful synergistic effect on fat reduction.
Shop this stackAOD-9604 + BPC-157
While AOD-9604 focuses on fat loss, BPC-157 can be added to support joint health and recovery, which is beneficial during a caloric deficit and increased activity.
Shop this stackFrequently Asked Questions
Is AOD-9604 a steroid or a form of HGH?
No, it's a peptide fragment. It's only the tail end of the human growth hormone molecule, specifically the part responsible for fat burning. It doesn't have the anabolic (muscle-building) or systemic growth effects of full HGH or anabolic steroids.
Will AOD-9604 help me build muscle?
Not directly. Its primary function is fat metabolism. While reducing fat can improve body composition and make muscle more visible, AOD-9604 does not stimulate muscle protein synthesis like full growth hormone or other anabolic agents.
How long does it take to see results with AOD-9604?
Fat loss is a gradual process. Most research protocols and user reports suggest consistent use for at least 12 weeks to see noticeable changes. It's not a quick fix; its effects are cumulative and work best with proper diet and exercise.
Do I need to diet and exercise while using AOD-9604?
Absolutely. AOD-9604 is a tool that enhances your body's ability to burn fat, not a magic pill that works in isolation. It is most effective when combined with a caloric deficit and a consistent exercise routine to create the right metabolic environment for fat loss.
More from this category
Compare nearby options in the same category before choosing a research product.
Cagrilintide
A potent, long-acting amylin analogue for significant appetite reduction and weight loss.
MOTS-c
The 'exercise in a bottle' peptide for metabolic health and mitochondrial function.
Retatrutide
The first-in-class triple agonist peptide setting a new benchmark for research in weight loss and metabolic health.
Semaglutide
A well-studied peptide for significant weight loss and blood sugar control.
You might also like
These peptides share research keywords or protocol overlap with AOD-9604.
CJC-1295
The long-acting GHRH for sustained growth hormone release and systemic benefits.
Weight Loss Peptides
Targeted fat loss through metabolic peptide protocols
Ready to Purchase AOD-9604?
Get pharmaceutical-grade AOD-9604 from Simple Peptide with 99%+ purity, third-party lab testing, and same-day dispatch.
Buy AOD-9604 Now